Fonseca, RaĆssa
Burn, Thomas N.
Gandolfo, Luke C. http://orcid.org/0000-0002-3599-2455
Devi, Sapna
Park, Simone L.
Obers, Andreas
Evrard, Maximilien http://orcid.org/0000-0002-2105-1160
Christo, Susan N.
Buquicchio, Frank A.
Lareau, Caleb A. http://orcid.org/0000-0003-4179-4807
McDonald, Keely M.
Sandford, Sarah K. http://orcid.org/0000-0002-2901-4516
Zamudio, Natasha M.
Zanluqui, Nagela G.
Zaid, Ali http://orcid.org/0000-0002-2528-2783
Speed, Terence P. http://orcid.org/0000-0002-5403-7998
Satpathy, Ansuman T. http://orcid.org/0000-0002-5167-537X
Mueller, Scott N. http://orcid.org/0000-0002-3838-3989
Carbone, Francis R.
Mackay, Laura K. http://orcid.org/0000-0002-8496-6632
Funding for this research was provided by:
Department of Health | National Health and Medical Research Council (AP1113293)
Bill and Melinda Gates Foundation (OPP1175796)
Article History
Received: 8 October 2021
Accepted: 17 June 2022
First Online: 26 July 2022
Competing interests
: The authors declare no competing interests. A.T.S. is a founder of Immunai and Cartography Biosciences and receives unrelated research funding from Merck Research Laboratories, Allogene Therapeutics, and Arsenal Biosciences, L.K.M. receives unrelated research funding from Pfizer.